ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

Tariffs on medical devices would push up prices and disrupt research and development efforts at the expense of US patients, ...

Hello, and welcome to the Q1 Fiscal Year 2026 ResMed Earnings Conference Call. My name is Kevin. I'll be your operator for today's call. [Operator Instructions] Also, please note, this conference call ...

Earnings call ResMed reported Q1 FY26 revenue of $1.34B, up 9% YoY (8% constant currency), with 280 bps gross margin expansion and 16% EPS growth. U.S. device and mask sales were strong, aided by ...

Much of David Gardner's advice bucks traditional investing wisdom. He doesn't recommend following the traditional wisdom to ...

The post Wife Gets Constantly Woken Up By The Whistling Sound Of Her Husband’s CPAP Machine, So She Wakes Him Up To Fix The ...

Pacific Sleep Apnea Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering.The Asia-Pacific Sleep Apnea Devices ...

Resmed (NYSE: RMD) + shares rose slightly today on third-quarter results that came in ahead of the consensus Wall Street forecast. Shares of RMD ticked up 2.5% to $258.60 apiece in post-market trading ...

With the growing emphasis on respiratory wellness and early intervention for sleep disorders, the UK CPAP market is poised to ...

Neru Health, an artificial intelligence (AI)-powered care automation platform for sleep clinics and durable medical equipment ...

Mayo Clinic doctors tap into AI technology to detect and treat women with sleep apnea, a disorder that's often misdiagnosed ...

Coca Cola Freestyle custom beverage machine in a Five Guys restaurant - PJ McDonnell/Shutterstock Who among us hasn't gotten overwhelmed in the presence of a Coca-Cola Freestyle machine? It's one of ...